Business Wire

ADVA

5.5.2022 09:02:06 CEST | Business Wire | Press release

Share
ADVA plays key role in new QKD projects to accelerate commercial rollout

ADVA (FSE: ADV) today announced that it’s playing a key role in three research and development (R&D) projects building future-proof secure communication networks based on quantum key distribution (QKD). Funded by Germany’s Federal Ministry of Education and Research (BMBF), the initiatives aim to address the significant cybersecurity threat posed by quantum hacking and create the next generation of quantum-safe transport infrastructure with technology made in Germany. In cooperation with other consortium partners, ADVA will accelerate the commercial adoption of QKD technology by making it deployable at scale, robust and easy to integrate.

“The looming threat of large quantum computers puts our most sensitive data at risk. There’s also the immediate danger of cybercriminals harvesting encrypted information now so they can decrypt it when quantum computers become accessible. This is why the switch to quantum-safe encryption is essential for the long-term security of critical data. QKD is based on quantum technology and protects the key exchange between communication endpoints. Even if there is future progress in decryption algorithms and computational capabilities, either classical or quantum, an adversary cannot intercept the keys,” said Michael Roth, GM at Network Security, ADVA. “We understand the requirements of both the quantum and the communication world. By lending our technology and know-how, we’re bridging the gap between them. The BMBF-funded initiatives we’re involved in will make QKD usable for commercial and government customers. Together with our partners, we’re moving this technology to the next level for robust, seamless deployment at scale in today’s optical networks.”

Each of the three projects involves a consortium of industry and research partners with leading expertise in quantum technologies, cryptography, optical communication, and network operation. Coordinated by Deutsche Telekom, the DemoQuanDT project will demonstrate secure quantum key exchange over a fiber optic link between Berlin and Bonn and investigate key management in a multi-vendor environment. Led by Infosim, the QuNet+ML project will research methods for optimizing quantum key distribution in large-scale networks using machine learning. And finally, the DE-QOR project led by ADVA will develop compact and cost-effective continuous-variable QKD (CV-QKD) technology compatible with existing metro and long-distance fiber infrastructure.

“QKD offers a way to achieve true long-term network security today. In just a few years, we’re likely to see current public key cryptosystems rendered obsolete by malicious actors with quantum computers, whether that’s criminal organizations seeking profit or state-sponsored actors aiming to infiltrate critical national infrastructure. It’s therefore crucial that we harness quantum technology quickly in order to stay ahead in the cybersecurity race. Our involvement in these latest BMBF projects is testament to ADVA’s role as a leader in this vital R&D space,” commented Helmut Griesser, director of advanced technology at ADVA. “From day one, our ConnectGuard™ encryption technology has been at the forefront of quantum-safe communication by offering an open, standards-based interface to external QKD systems. Leveraging our expertise in coherent transmission, digital signal processing and cryptography, we’re now working towards our own CV-QKD solution to give customers more choice.”


About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Angel Aligner Unveils Six Innovations for 202711.11.2026 17:23:00 CET | Press release

Angel Elevates the Orthodontic Specialty by Focusing on Complex-Case Solutions Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATMsystem for next generation growth guidance for young patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110338654/en/ Unveiling Angel's 2027 Innovations. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver said: “In over 4 decades, I’ve never had a parent say I’d be happy if you ensure that my child’s treatment results are average.” Angel is committed to elevating the orthodontic specialty well above the average, especially as more competition and harder referral cases demand outstanding results. Bind

Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation11.11.2026 15:58:00 CET | Press release

Partnerships span drug discovery, clinical research, preventive and reproductive health Launch of an AI Clinician Framework and a Trusted Research Environment for health and genomic data Four whitepapers address genomics, therapeutics, fertility and wearable technologies New programmes support health innovators and entrepreneurs More than 17,300 visitors from 85 countries, with 130 speakers across 45 sessions Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 concluded with agreements and initiatives spanning drug discovery, clinical research, preventive and reproductive health, alongside research and entrepreneurship programmes that will sustain collaboration beyond the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111545964/en/ The Summit is the annual flagship gath

De' Longhi Group: Record Results for the Quarter, With Revenue Growing by 7.7% and Net Profit Pertaining to the Group Progressing Significantly by 19%11.11.2026 15:58:00 CET | Press release

The Board of Directors of De' Longhi S.p.A. approved the consolidated results1 for the nine months of 2026. In the nine months the Group achieved: revenues for € 2,621.3 million, up by 6.5% with respect to 2025 (+7.7% at constant currency); an adjusted2 Ebitda of € 455.2 million, equal to 17.4% on revenues (vs. 15.8% with respect to last year); a net income pertaining to the Group equal to € 225.8 million (+20.4% with respect to last year); a positive net financial position equal to € 606.0 million. CEO Fabio de' Longhi commented: “The Group delivered its thirteenth consecutive quarter of organic revenue growth, underscoring our proven ability to capitalize on industry opportunities and respond promptly to market evolution, while ensuring consistent performance across both divisions. The professional business recorded a strong acceleration, spanning all geographies and brands, with revenues growth exceeding 35% for both the quarter and the nine-month period, this against an already par

Starr Chile Assigned A Rating from AM Best11.11.2026 14:30:00 CET | Press release

Starr, a global insurance and investment organization, today announced that the global credit rating agency AM Best has assigned Starr International Seguros Generales S.A. (Starr Chile) a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent). The outlook for both credit ratings is positive. The rating reflects Starr’s strong balance sheet and Starr Chile’s successful implementation of Starr’s business model. AM Best also cited Starr’s operating performance, a favorable business profile and enterprise risk management as key factors supporting the positive rating. “This strong rating is another important endorsement of Starr’s business model as we continue to build our presence in Latin America,” said Jeff Greenberg, chairman and co-CEO of Starr. “It reflects the financial strength, underwriting discipline and experienced teams that underpin our business around the world, reinforcing the confidence brokers and clients can place in Starr.” Starr

Epinal, Inc. Emerges from Stealth with First-of-Its-Kind Breakthrough Semiconductor Electrochemical Biosensor (SEB) for Detection of Narcotics and Disease Biomarkers in Human Breath in Minutes11.11.2026 14:22:00 CET | Press release

Southern California-Based Company has developed a disruptive biosensor for integration into next-generation screening and diagnostic devices Epinal, Inc., after over six years of under-the-radar development, has officially emerged from stealth mode, introducing a breakthrough Semiconductor Electrochemical Biosensor (SEB) designed to detect narcotics and disease biomarkers directly from human breath in minutes. By combining advanced semiconductors, electrochemical sensing, tailored protein engineering, and artificial intelligence, Epinal has addressed the historical sensitivity, selectivity, scaling, stability, and signal-to-noise limitations that have long bottlenecked biosensors. Epinal’s Semiconductor Electrochemical Biosensor (SEB) will be integrated into the next generation of low cost, disposable, single-use breathalyzer cartridges where the integrity of test results is of utmost importance. In the case of narcotic detection, a rapid, non-invasive, and objective result changes an

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye